In this light, future research should assess SIRT1 changes in the human brain across healthy, MCI, and late AD stages, and whether long-term bioavailability of n-3-derived SPMs can mediate microglial respiration and phagocytosis in response to stimuli in the inflammaging brain via SIRT1 activity. This evidence concerns the gene SIRT1 and Alzheimer disease.